Sensus Healthcare (NSDQ:SRTS), narrowly beat analysts’ earnings expectations for the second quarter but missed the consensus sales forecast, sending share prices down today.
Boca Raton, Fla.-based Sensus posted net losses of -$540,651, or -4¢ per share, on sales of $6.1 million for the three months ended June 30, cutting its losses by -29.2% on sales growth of 21.9% compared with Q2 2017.
Analysts on Wall Street predicted losses per share of -5¢ on sales of $6.6 million.
Get the full story on our sister site, Medical Design & Outsourcing.
The post Sensus squeaks past Wall Street Q2 expectations appeared first on MassDevice.
from MassDevice https://ift.tt/2vzXc2m
Cap comentari:
Publica un comentari a l'entrada